FI20075063A0 - Allergisen herkistymisen estäminen - Google Patents

Allergisen herkistymisen estäminen

Info

Publication number
FI20075063A0
FI20075063A0 FI20075063A FI20075063A FI20075063A0 FI 20075063 A0 FI20075063 A0 FI 20075063A0 FI 20075063 A FI20075063 A FI 20075063A FI 20075063 A FI20075063 A FI 20075063A FI 20075063 A0 FI20075063 A0 FI 20075063A0
Authority
FI
Finland
Prior art keywords
prevention
allergic sensitization
sensitization
allergic
Prior art date
Application number
FI20075063A
Other languages
English (en)
Swedish (sv)
Inventor
Hanna Viskari
Mikael Knip
Tapio Seiskari
Heikki Hyoety
Original Assignee
Vactech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vactech Oy filed Critical Vactech Oy
Priority to FI20075063A priority Critical patent/FI20075063A0/fi
Publication of FI20075063A0 publication Critical patent/FI20075063A0/fi
Priority to PCT/FI2008/050032 priority patent/WO2008092996A1/en
Priority to KR1020097017431A priority patent/KR20090107545A/ko
Priority to NZ578362A priority patent/NZ578362A/en
Priority to CA002676624A priority patent/CA2676624A1/en
Priority to EP08709301.9A priority patent/EP2114448B1/en
Priority to RU2009132487/15A priority patent/RU2429881C2/ru
Priority to CN200880003712A priority patent/CN101646454A/zh
Priority to US12/523,328 priority patent/US8182805B2/en
Priority to AU2008211810A priority patent/AU2008211810B2/en
Priority to JP2009547721A priority patent/JP2010517982A/ja
Priority to BRPI0807059-8A priority patent/BRPI0807059A2/pt
Priority to ZA200905104A priority patent/ZA200905104B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI20075063A 2007-02-01 2007-02-01 Allergisen herkistymisen estäminen FI20075063A0 (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20075063A FI20075063A0 (fi) 2007-02-01 2007-02-01 Allergisen herkistymisen estäminen
BRPI0807059-8A BRPI0807059A2 (pt) 2007-02-01 2008-01-31 Uso de enterovírus, e, método para prevenir ou tratar de uma doença
CA002676624A CA2676624A1 (en) 2007-02-01 2008-01-31 Prevention of allergic sensitization
KR1020097017431A KR20090107545A (ko) 2007-02-01 2008-01-31 알레르기 민감성의 예방
NZ578362A NZ578362A (en) 2007-02-01 2008-01-31 Prevention of ige mediated allergic sensitization using enterovirus
PCT/FI2008/050032 WO2008092996A1 (en) 2007-02-01 2008-01-31 Prevention of allergic sensitization
EP08709301.9A EP2114448B1 (en) 2007-02-01 2008-01-31 Prevention of allergic sensitization
RU2009132487/15A RU2429881C2 (ru) 2007-02-01 2008-01-31 Предотвращение аллергической сенсибилизации
CN200880003712A CN101646454A (zh) 2007-02-01 2008-01-31 变应性致敏的预防
US12/523,328 US8182805B2 (en) 2007-02-01 2008-01-31 Prevention of allergic sensitization
AU2008211810A AU2008211810B2 (en) 2007-02-01 2008-01-31 Prevention of allergic sensitization
JP2009547721A JP2010517982A (ja) 2007-02-01 2008-01-31 アレルギー感作の防止
ZA200905104A ZA200905104B (en) 2007-02-01 2009-07-21 Prevention of allergic sensitization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075063A FI20075063A0 (fi) 2007-02-01 2007-02-01 Allergisen herkistymisen estäminen

Publications (1)

Publication Number Publication Date
FI20075063A0 true FI20075063A0 (fi) 2007-02-01

Family

ID=37832218

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075063A FI20075063A0 (fi) 2007-02-01 2007-02-01 Allergisen herkistymisen estäminen

Country Status (13)

Country Link
US (1) US8182805B2 (fi)
EP (1) EP2114448B1 (fi)
JP (1) JP2010517982A (fi)
KR (1) KR20090107545A (fi)
CN (1) CN101646454A (fi)
AU (1) AU2008211810B2 (fi)
BR (1) BRPI0807059A2 (fi)
CA (1) CA2676624A1 (fi)
FI (1) FI20075063A0 (fi)
NZ (1) NZ578362A (fi)
RU (1) RU2429881C2 (fi)
WO (1) WO2008092996A1 (fi)
ZA (1) ZA200905104B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012301814A1 (en) 2011-08-31 2014-02-27 Perosphere Technologies Inc. Methods for effectively and rapidly desensitizing allergic patients
US11096994B2 (en) 2012-10-30 2021-08-24 Aravax Pty Ltd Immunotherapeutic molecules and uses thereof
RU2689552C2 (ru) * 2013-09-25 2019-05-28 Аравакс Пти Лтд Новая иммунотерапевтическая композиция и ее применения
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9206981A (es) 1991-12-06 1994-08-31 Whitehead Biomedical Inst Vacunas de recombinantes y metodo para producirlas.
DE60014077T2 (de) * 1999-06-24 2005-10-20 Heikki Hyöty Vorbeugung von typ-1 diabetes und anderen nicht-polio enteroviren
US7090855B1 (en) * 1999-06-24 2006-08-15 Hyoety Heikki Prevention of Type 1 diabetes and other non-polio enterovirus diseases
SE528319C2 (sv) 2004-09-17 2006-10-17 Forskarpatent I Syd Ab Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn

Also Published As

Publication number Publication date
BRPI0807059A2 (pt) 2014-04-22
CA2676624A1 (en) 2008-08-07
US8182805B2 (en) 2012-05-22
RU2009132487A (ru) 2011-03-10
AU2008211810A1 (en) 2008-08-07
NZ578362A (en) 2011-09-30
JP2010517982A (ja) 2010-05-27
US20100034848A1 (en) 2010-02-11
EP2114448B1 (en) 2015-12-09
KR20090107545A (ko) 2009-10-13
EP2114448A4 (en) 2012-07-25
EP2114448A1 (en) 2009-11-11
WO2008092996A1 (en) 2008-08-07
CN101646454A (zh) 2010-02-10
AU2008211810B2 (en) 2012-10-25
RU2429881C2 (ru) 2011-09-27
ZA200905104B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
BRPI0810179A2 (pt) Composições de oligo-guluronato e galacturonato
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
BRPI1011587A2 (pt) compostos e composições terapèuticas
ATE528296T1 (de) Polymorphe form von 4-ä3-(4- cyclopropancarbonylpiperazin-1-carbonyl)-4- fluorbenzylü-2h-phthalazin-1-on
BRPI0906980A2 (pt) Composição de derivados e maleatados
JP2006122056A5 (ja) β-グルカンの使用
BRPI0820928A2 (pt) Fabricação de elementos com baixa fricção
FI20060854A0 (fi) Invertterien rinnankytkentä
DK2111555T3 (da) Diagnosticering af præeklampsi
MA29065B1 (fr) Variete de framboisier nome driscoll sevillana
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2114147T3 (da) Reduktion af bivirkninger af tramadol
BRPI0812087A2 (pt) Processos de formação de pré-formas de silenciosos
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
FI20065834A0 (fi) Iskulaite
DK2175849T3 (da) Behandling af melanomer
CU23884B1 (es) Derivados de dibenzotiazepina
DK2118174T3 (da) Anvendelse af tocopherol
DK2173197T3 (da) Fremgangsmåde
FI20075063A0 (fi) Allergisen herkistymisen estäminen
FI20060590A (fi) Nanohiukkasten valmistus
ITBS20080136A1 (it) Profilato di tapparella e tapparella
ITVR20060143A1 (it) Perfezionamento di materasso
FI20085971A0 (fi) Betaiinin käyttö
ITCH20060016A1 (it) Rilevatore-segnalatore di allagamenti